Comparison of patients with and without new tachyarrhythmias
Comparison of patients with new tachyarrhythmias with the no arrhythmias group (Supplementry Table 1) shows that patients with new tachyarrhythmias (n=25, 6.4%) were older, had more comorbidities, and experienced a more severe disease. Rate of respiratory symptoms was higher among patients with new tachyarrhythmias, however it was not statistically significant (p=0.07). As expected, more patients with new tachyarrhythmias received a QT prolonging drug which included mainly anti-arrhythmic medications. Differences in other ECG and laboratory results are further described in Supplementary table 1.